x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Global Women"s Health Academy

The Global Women"s Health Academy (GWHA) series features late-breaking women"s health education from leading clinical and public health experts across the world. For more information about GWHA, visit www.globalwomenshealthacademy.org.

science & medicine medicine

All Episodes

00:00:00

Addressing Myths and Missteps in Uterine Fibroid Care

Global Women"s Health Academy ·

2025/05/30

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP Despite longstanding reliance on surgery, recent advancements have reshaped our approach to uterine fibroids. However, common myths and misconceptions have limited the adoption of newer therapies, leaving many patients unaware of their available options. Join Dr. Charles Turck and Dr. Ayman Al-Hendy as they explain shifting treatment paradigms and patient education strategies in uterine

en

00:00:00

Detecting ESR1 Mutations in Metastatic Breast Cancer:...

Global Women"s Health Academy ·

2023/12/04

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Pavani Chalasani, MD, MPH Acquired ESR1 mutations cannot be detected on archival tissue and require liquid biopsy. Fortunately, this approach circumvents the challenges of acquiring serial tissue while allowing for the real-time monitoring of ESR1 status in patients with metastatic breast cancer. Learn more about the rationale behind liquid biopsies and best practices for utilizing them in clinical practice with Dr. Charles Turck and

en

00:00:00

Best Practices for Detecting ESR1 Mutations in...

Global Women"s Health Academy ·

2023/12/01

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Stephanie Graff, MD Guest: Pavani Chalasani, MD, MPH When treating patients with metastatic breast cancer, it’s important to repeatedly conduct liquid biopsies to look for acquired ESR1 mutations when patients progress after endocrine therapy, even if initial testing was done. That’s why Dr. Charles Turck is breaking down best practices for utilizing liquid biopsies to detect ESR1 mutations with Drs. Stephanie Graff and Pavani

en

00:00:00

How Testing for Acquired vs. Intrinsic Mutations in...

Global Women"s Health Academy ·

2023/11/30

Guest: Megan Kruse, MD While intrinsic mutations, like PIK3CA, are present at the outset and can be identified upfront in patients with HR+/HER2- metastatic breast cancer, acquired mutations, like ESR1, cannot be detected on baseline tumor profiling. That’s why longitudinal monitoring with liquid biopsies over the course of treatment is required. Learn more about these key differences in testing for acquired versus intrinsic mutations with Dr. Megan Kruse, a breast medical oncologist

en

00:00:00

Optimizing Vulvovaginitis Care: A Look at Screening...

Global Women"s Health Academy ·

2023/05/26

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Oluwatosin Goje, MD A delay in diagnosis and treatment of vulvovaginitis can have big impacts on a patient’s quality of life and their overall health. Explore how screening modalities like molecular tests and treatment guidelines from the CDC can help optimize the management of patients with vulvovaginitis with Dr. Charles Turck and Dr. Tosin Goje, Associate Professor of Obstetrics and Gynecology and Reproductive Biology at the

en

00:00:00

Reducing the Burden of Vulvovaginitis with Improved...

Global Women"s Health Academy ·

2023/05/26

Guest: Oluwatosin Goje, MD Better diagnostic techniques with rapid turnover and therapies for the treatment of both acute and chronic vulvovaginitis can help address the long-term burden facing reproductive-aged women. Learn more with Dr. Tosin Goje, Associate Professor of Obstetrics/Gynecology and Reproductive Biology at the Cleveland Clinic's Lerner College of Medicine at Case Western Reserve University.

en

00:00:00

Selecting Therapy for ER+/HER2- Metastatic Breast...

Global Women"s Health Academy ·

2023/05/12

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Megan Kruse, MD From disease-related factors to the latest clinical trial data, there’s a lot to consider when selecting a therapy for patients with ER+/HER2- metastatic breast cancer. Here with Dr. Charles Turck to break down the key factors that can guide our treatment selections is breast medical oncologist Dr. Megan Kruse from the Cleveland Clinic in Ohio.

en

00:00:00

Treating Metastatic Breast Cancer After the...

Global Women"s Health Academy ·

2023/03/31

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Hope S. Rugo, MD, FASCO The treatment landscape for metastatic breast cancer is rapidly evolving. With all of these new advancements and research, it can be helpful to review the available treatment options and best practices for selecting an approach after treatment with a CDK4/6 inhibitor has failed. That’s why Dr. Charles Turck discusses how we can treat patients with metastatic breast cancer in the second- and third-line setting

en

00:00:00

Freeze-All Policy: Is It Right for Everyone?

Global Women"s Health Academy ·

2017/11/27

Host: Matheus Roque, M.D. Dr. Matheus Roque will review current studies and papers exploring the rationale and effectiveness of a freeze-all policy, as well as discuss how to identify the proper patient population to benefit from this technique.

en

9 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事